本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带 责任。 中国银河证券股份有限公司 2026 年度第二期短期融资券已于 2026 年 1 月 14 日发行完毕，相关发行情况如下： | 债券名称 | 中国银河证券股份有限公司 | 2026 | 年度第二期短期融资券 | | --- | --- | --- | --- | | 债券简称 | 26 银河证券 CP002 | 债券流通代码 | 072610005 | | 发行日 | 2026 年 1 月 13 日 | 起息日 | 2026 年 1 月 14 日 | | 到期兑付日 | 2026 年 9 月 18 日 | 期限 | 247 天 | | 计划发行总额 | 50 亿元人民币 | 实际发行总额 | 50 亿元人民币 | | 票面年利率 | 1.71% | 发行价格 | 100 元/百元面值 | 本 期 发 行 短 期 融 资 券 的 相 关 文 件 已 刊 登 在 中 国 货 币 网 （www.chinamoney.com.cn）、上海清算所网站（www.shclearing.c ...

Group 1 - The core viewpoint of the news is that ST Sike Rui (688053.SH) is currently experiencing a decline in stock price, with a closing price of 48.68 yuan and a drop of 4.70%, resulting in a total market value of 4.868 billion yuan [1] - ST Sike Rui was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 8, 2022, with an initial public offering (IPO) of 25 million shares at a price of 55.53 yuan per share [1] - The total amount raised from the IPO was 138.825 million yuan, with a net amount of 125.251 million yuan, which exceeded the original plan by 63.394 million yuan [1] - The funds raised are intended for various projects, including the construction of testing bases in Chengdu and Wuxi, an environmental testing center, a research and development center, and to supplement working capital [1] - The total issuance costs for the IPO amounted to 13.574 million yuan, with the lead underwriter, China Galaxy Securities Co., Ltd., receiving 10.760 million yuan in underwriting and sponsorship fees [1] Group 2 - On September 20, 2025, ST Sike Rui announced the implementation of other risk warnings and a suspension of trading due to receiving an administrative penalty notice from the Sichuan Regulatory Bureau of the China Securities Regulatory Commission [2] - The stock abbreviation for A-shares will change from "Sike Rui" to "ST Sike Rui," and the expanded abbreviation will change from "Sike Rui Microelectronics" to "ST Sike Rui Microelectronics," with the risk warning effective from September 23, 2025 [2]

雷科防务今日跌9.99%，成交额71.27亿元，换手率33.07%，盘后龙虎榜数据显示，深股通专用席位买入 454.21万元并卖出1.01亿元，有1家机构专用席位净卖出8303.51万元。中国银河大连黄河路净卖出2.94亿 元。 ...

Core Viewpoint - Lianchi Hospital Group Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with China Galaxy International as the sole sponsor [1] Group 1: Company Overview - Lianchi Hospital is a boutique specialty medical group with Chinese characteristics, operating 5 hospitals and 1 elderly care institution under a group management structure by September 30, 2025 [1] - The company adheres to a "patient-first" philosophy and implements a "human-centered medical" management model, establishing the well-known "Lianchi Medical" brand [1] Group 2: Unique Medical Services - Lianchi Hospital offers distinctive medical service models, including painless management, enhanced recovery after surgery (ERAS), integrated medical and nursing care, and no-companion nursing [1] - According to Frost & Sullivan data, Lianchi Hospital has become one of the most influential medical groups in China [1]

Core Viewpoint - The passenger car market in December shows significant divergence, with the implementation of the 2026 vehicle trade-in policy expected to benefit the mid-to-high-end market segment [1][3] Market Performance - In December, retail sales of passenger cars reached 2.261 million units, down 14.0% year-on-year but up 1.6% month-on-month; wholesale sales were 2.789 million units, down 9.0% year-on-year and down 7.0% month-on-month [2] - The overall industry inventory decreased by 60,000 units in December, indicating cautious market conditions prompting dealers to actively reduce inventory [2] - The retail penetration rate for new energy vehicles (NEVs) reached 59.1%, up 9.6 percentage points year-on-year, while the wholesale penetration rate was 56.0%, up 6.6 percentage points year-on-year [2] Policy Impact - The 2026 vehicle trade-in policy introduces a proportional subsidy that favors the 150,000 to 200,000 price segment, which is expected to improve the sales structure of new vehicles [3] - The new policy will provide subsidies of 12% (up to 20,000 yuan) for NEVs and 8% (up to 15,000 yuan) for fuel vehicles, with the overall funding for the 2026 policy set at 625 billion yuan, a reduction compared to the previous year's 3 trillion yuan [3] Future Outlook - The consumer purchasing sentiment is expected to stabilize in January 2026 due to the early implementation of the trade-in policy and the backlog of year-end orders [4] - The market is anticipated to experience a smooth transition in sales as the new policy is expected to mitigate price wars and internal competition [4] Sector Performance - In the recent bi-weekly review, the performance of various sectors showed increases, with parts (+7.24%), commercial vehicles (+2.80%), and passenger vehicles (+2.08%) leading the gains [5] - Valuation metrics indicate that the price-to-earnings ratios for sales and services, parts, motorcycles, passenger vehicles, and commercial vehicles are 36.18x, 33.83x, 26.73x, 22.74x, and 16.73x respectively [5]

Company Overview - Lianchi Hospital has submitted a listing application to the Hong Kong Stock Exchange, with China Galaxy International as the exclusive sponsor [1] - The company is positioned as a high-quality specialty medical group with a focus on patient-centered care and innovative medical service models [1] - By September 30, 2025, the company plans to operate 5 hospitals and 1 elderly care facility, with a total building area of approximately 117,900 square meters and 786 registered beds [1] Operational Performance - As of September 30, 2025, the company has a medical team consisting of 341 practicing physicians and assistant doctors [1] - The outpatient visits, inpatient admissions, orthopedic surgeries, and childbirths are expected to maintain a high level through 2023, 2024, and the first nine months of 2025 [1] - According to Frost & Sullivan, Lianchi Orthopedic Hospital ranks first in Shandong Province and third nationwide in terms of private hospital knee surgery volume for 2024 [1] Industry Trends - The Chinese healthcare service market is experiencing overall growth, with the private hospital sector being one of the fastest-growing components [2] - Revenue from private hospitals increased from RMB 437.9 billion in 2019 to RMB 689.2 billion in 2023, reflecting a compound annual growth rate (CAGR) of 12.0% [2] - It is projected that the revenue for private hospitals will reach RMB 1.88 trillion by 2030, with a CAGR of 12.2% from 2024 to 2030 [2]

Core Viewpoint - China Galaxy Securities has received approval from the China Securities Regulatory Commission (CSRC) to publicly issue corporate bonds totaling up to 30 billion yuan to professional investors [1]. Group 1 - The company has been granted a registration approval for the issuance of corporate bonds with a total face value not exceeding 30 billion yuan [1]. - The approval from CSRC is valid for 24 months from the date of consent, allowing the company to issue the bonds in multiple tranches during this period [1]. - The company will comply with relevant laws, regulations, and the requirements of the approval, and will fulfill its information disclosure obligations in a timely manner [1].

中国银河证券指出，脑机接口技术正从实验室迈向产业化生产。近期，马斯克旗下公司Neuralink宣布， 计划在2026年启动脑机接口设备的大规模量产，并推进全自动化外科手术流程。全球脑机接口产业正迎 来快速发展，其技术路径主要分为侵入式和非侵入式两种，产业链覆盖材料、芯片、手术及医疗康复等 多个领域。近年来，我国从国家到地方层面密集出台的系列政策以及医保定价、优先审批等支持措施， 明确了脑机接口产业发展方向，并为中国脑机接口产业的商业化落地和创新追赶提供了强力保障。 ...

（文章来源：第一财经） 中国银河证券表示，把握"AI飞跃 + 百年变局"共振下的超级铜周期。回顾历史，每一轮超级铜周期都 对应一段清晰而强大的宏观叙事，而本轮周期同时叠加了"人工智能科技革命"与"全球秩序重塑"两大长 期逻辑，其持续性和战略意义不亚于战后重建、我国对外开放等历史阶段。中国银河证券认为，铜价依 然有较大上行空间。其一，虽铜价已履创新高，但根据历史复盘结果，剔除通胀因素之后的铜价尚未达 到前几轮超级周期的高度。其二，国际货币秩序正在重塑，美元作为大类资产价格锚的基础正在弱化， 如果以黄金作为标尺，当前铜金比价仍然处在历史低位。投资层面，应以中长期视角重新审视铜的配置 价值，重点关注铜资源端、优质矿企及与电力、AI 基础设施高度相关的产业链环节，把握超级铜周期 下由需求扩张与供给刚性共同驱动的投资机会。 ...

Core Viewpoint - China Galaxy Securities has received approval from the China Securities Regulatory Commission (CSRC) to publicly issue corporate bonds totaling up to 30 billion yuan to professional investors [1] Group 1: Stock Performance - As of January 13, 2026, China Galaxy's stock closed at 16.06 yuan, down 1.17% from the previous trading day [1] - The stock opened at 16.28 yuan, reached a high of 16.36 yuan, and a low of 16.01 yuan on the same day [1] - The total market capitalization of the company is 175.607 billion yuan, with a trading volume of 8.57 billion yuan and a turnover rate of 0.73% [1] Group 2: Bond Issuance - The approval from CSRC is valid for 24 months from the date of registration, allowing the company to issue bonds in multiple tranches within this period [1] - The company will comply with relevant laws, regulations, and shareholder authorizations in the bond issuance process and will fulfill its information disclosure obligations [1]